首页> 外国专利> DIAGNOSTIC METHODS INVOLVING DETERMINING GENE COPY NUMBERS AND SNPs IN THE Fc RII/Fc RIII GENE CLUSTER, AND PROBES FOR USE IN SUCH METHODS TO DETECT SUSCEPTIBILITY TO AND TREATMENT EFFICACY IN AUTOIMMUNE DISEASES

DIAGNOSTIC METHODS INVOLVING DETERMINING GENE COPY NUMBERS AND SNPs IN THE Fc RII/Fc RIII GENE CLUSTER, AND PROBES FOR USE IN SUCH METHODS TO DETECT SUSCEPTIBILITY TO AND TREATMENT EFFICACY IN AUTOIMMUNE DISEASES

机译:确定Fc RII / Fc RIII基因簇中基因拷贝数和SNP的诊断方法,以及用于检测自身免疫性疾病的易感性和治疗效率的此类方法的问题

摘要

The invention relates to diagnostic methods to predict whether a subject is predisposed for acquiring a disease or to predict the therapy responsiveness of an individual patient. Provided is a method for determining whether a subject is predisposed for developing an autoimmune disease, comprising determining in a sample isolated from said subject the amount of intact genes, or gene products thereof, of the FcRII/FcRIII gene cluster, said gene cluster comprising the FCGR2C, FCGR3A, FCGR2A and FCGR3B genes encoding an activating FcR, and FCGR2B encoding an inhibitory Fc R; and correlating said amount to the amount observed in a healthy population. Also provided is a method to predict the responsiveness of a subject to therapy with intravenous immunoglobulin (IVIg) therapy or a monospecific biological, such as a humanized or human monoclonal antibody or a chimeric molecule, comprising the C-terminal Fc-tail of IgG.
机译:本发明涉及预测对象是否倾向于患病或预测单个患者的治疗反应性的诊断方法。提供了一种确定受试者是否易患自身免疫疾病的方法,其包括确定从所述受试者分离的样品中FcRII / FcRIII基因簇的完整基因或其基因产物的量,所述基因簇包括编码激活的FcR的FCGR2C,FCGR3A,FCGR2A和FCGR3B基因,以及编码抑制性Fc R的FCGR2B;并将所述量与健康人群中观察到的量相关联。还提供了一种预测受试者对用静脉内免疫球蛋白(IVIg)疗法或包含IgG的C-末端Fc-尾的单特异性生物学例如人源化或人单克隆抗体或嵌合分子的疗法的反应性的方法。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号